Cargando…

Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event

There is an ongoing debate on the COVID-19 infection fatality rate (IFR) and the impact of COVID-19 on overall population mortality. Here, we addressed these issues in a community in Germany with a major superspreader event analyzing deaths over time and auditing death certificates in the community....

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Enrico, Liebl, Dominik, Schulte, Bianca, Lehmann, Nils, Fuhrmann, Christine, Jöckel, Karl-Heinz, Ioannidis, John P. A., Streeck, Hendrik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069345/
https://www.ncbi.nlm.nih.gov/pubmed/37012282
http://dx.doi.org/10.1038/s41598-023-32441-7
_version_ 1785018827811061760
author Richter, Enrico
Liebl, Dominik
Schulte, Bianca
Lehmann, Nils
Fuhrmann, Christine
Jöckel, Karl-Heinz
Ioannidis, John P. A.
Streeck, Hendrik
author_facet Richter, Enrico
Liebl, Dominik
Schulte, Bianca
Lehmann, Nils
Fuhrmann, Christine
Jöckel, Karl-Heinz
Ioannidis, John P. A.
Streeck, Hendrik
author_sort Richter, Enrico
collection PubMed
description There is an ongoing debate on the COVID-19 infection fatality rate (IFR) and the impact of COVID-19 on overall population mortality. Here, we addressed these issues in a community in Germany with a major superspreader event analyzing deaths over time and auditing death certificates in the community.18 deaths that occurred within the first six months of the pandemic had a positive test for SARS-CoV-2. Six out of 18 deaths had non-COVID-19 related causes of death (COD). Individuals with COVID-19 COD typically died of respiratory failure (75%) and tended to have fewer reported comorbidities (p = 0.029). Duration between first confirmed infection and death was negatively associated with COVID-19 being COD (p = 0.04). Repeated seroprevalence essays in a cross-sectional epidemiological study showed modest increases in seroprevalence over time, and substantial seroreversion (30%). IFR estimates accordingly varied depending on COVID-19 death attribution. Careful ascertainment of COVID-19 deaths is important in understanding the impact of the pandemic.
format Online
Article
Text
id pubmed-10069345
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100693452023-04-04 Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event Richter, Enrico Liebl, Dominik Schulte, Bianca Lehmann, Nils Fuhrmann, Christine Jöckel, Karl-Heinz Ioannidis, John P. A. Streeck, Hendrik Sci Rep Article There is an ongoing debate on the COVID-19 infection fatality rate (IFR) and the impact of COVID-19 on overall population mortality. Here, we addressed these issues in a community in Germany with a major superspreader event analyzing deaths over time and auditing death certificates in the community.18 deaths that occurred within the first six months of the pandemic had a positive test for SARS-CoV-2. Six out of 18 deaths had non-COVID-19 related causes of death (COD). Individuals with COVID-19 COD typically died of respiratory failure (75%) and tended to have fewer reported comorbidities (p = 0.029). Duration between first confirmed infection and death was negatively associated with COVID-19 being COD (p = 0.04). Repeated seroprevalence essays in a cross-sectional epidemiological study showed modest increases in seroprevalence over time, and substantial seroreversion (30%). IFR estimates accordingly varied depending on COVID-19 death attribution. Careful ascertainment of COVID-19 deaths is important in understanding the impact of the pandemic. Nature Publishing Group UK 2023-04-03 /pmc/articles/PMC10069345/ /pubmed/37012282 http://dx.doi.org/10.1038/s41598-023-32441-7 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Richter, Enrico
Liebl, Dominik
Schulte, Bianca
Lehmann, Nils
Fuhrmann, Christine
Jöckel, Karl-Heinz
Ioannidis, John P. A.
Streeck, Hendrik
Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title_full Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title_fullStr Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title_full_unstemmed Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title_short Analysis of fatality impact and seroprevalence surveys in a community sustaining a SARS-CoV-2 superspreading event
title_sort analysis of fatality impact and seroprevalence surveys in a community sustaining a sars-cov-2 superspreading event
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10069345/
https://www.ncbi.nlm.nih.gov/pubmed/37012282
http://dx.doi.org/10.1038/s41598-023-32441-7
work_keys_str_mv AT richterenrico analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT liebldominik analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT schultebianca analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT lehmannnils analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT fuhrmannchristine analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT jockelkarlheinz analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT ioannidisjohnpa analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent
AT streeckhendrik analysisoffatalityimpactandseroprevalencesurveysinacommunitysustainingasarscov2superspreadingevent